Targeted cancer therapeutics: the heartbreak of success
- PMID: 16892027
- DOI: 10.1038/nm0806-881
Targeted cancer therapeutics: the heartbreak of success
Comment on
-
Cardiotoxicity of the cancer therapeutic agent imatinib mesylate.Nat Med. 2006 Aug;12(8):908-16. doi: 10.1038/nm1446. Epub 2006 Jul 23. Nat Med. 2006. PMID: 16862153
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
